封面
市場調查報告書
商品編碼
1623657

美國真皮填充劑市場評估:按產品類型、應用、成分、最終用戶和地區劃分的機會和預測(2018-2032 年)

United States Dermal Fillers Market Assessment, By Product Type, By Application, By Ingredients, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日期: | 出版商: Market Xcel - Markets and Data | 英文 122 Pages | 商品交期: 3-5個工作天內

價格

美國真皮填充劑市場規模預計將從 2024 年的 20.2 億美元成長到 2032 年的 35.3 億美元,預測期內的複合年增長率為 7.21%。

皮膚填充劑市場正在迅速擴大,反映出消費者對非侵入性美容手術和美容的興趣日益濃厚。可注射真皮填充劑具有撫平皺紋、恢復體積和改善臉部線條的潛力,因此成為那些希望在不接受手術的情況下改變外觀的人的熱門選擇。這一市場擴張是由幾個關鍵因素推動的。首先,這些治療的需求是由於與年齡相關的問題(例如皺紋和體積損失)的發病率不斷增加。此外,由於患者青睞恢復期較短且治療效果較有效的治療方法,因此患者明顯傾向選擇侵入性較小的治療方法。填料成分的技術發展帶來了顯著的市場成長。可生物降解的填充劑和安全性更高的填充劑等創新正在吸引更多有環保意識的客戶,並為醫療專業人士提供更多的治療選擇。此外,社群媒體的影響力創造了一個重視整容並使其正常化的社會,尤其是渴望達到理想化美麗標準的年輕一代。在人口趨勢、技術進步和文化變遷的推動下,真皮填充劑市場預計在未來幾年將大幅成長。

本報告調查了美國真皮填充劑市場,並提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構、影響市場成長的因素分析、案例研究、競爭格局和主要公司的概況。

目錄

第1章 專案範圍與定義

第2章 研究方法

第3章 執行摘要

第 4 章 美國皮膚填充劑市場的前景

  • 市場規模分析與預測
  • 市佔率分析/預測
    • 按產品類型
    • 按用途
    • 按材質
    • 按最終用戶
    • 按地區
    • 公司佔有率分析(前 5 名及其他)
  • 市場地圖分析

第5章 供需分析

第6章價值鏈分析

第7章 波特五力分析

第 8 章 PESTLE 分析

第9章價格分析

第10章 市場動態

  • 市場驅動力
  • 市場課題

第11章市場趨勢與發展

第12章 監理架構與創新

  • 臨床試驗
  • 監管審批

第13章 專利情況

第14章案例研究

第15章 競爭格局

  • 前 5 名競賽矩陣
  • 前5名企業SWOT分析
  • 前8名企業現狀
    • Galderma SA
    • Bioplus Co., Ltd.
    • Prollenium Medical Technologies Inc.
    • BIOXIS Pharmaceuticals SAS
    • Sinclair, Inc.
    • Allergan Aesthetics (AbbVie Inc.)
    • Medytox Inc.
    • SciVision Biotech Inc.

第16章 戰略建議

第17章 關於我們/免責聲明

Product Code: MX12495

United States dermal fillers market is projected to witness a CAGR of 7.21% during the forecast period 2025-2032, growing from USD 2.02 billion in 2024 to USD 3.53 billion in 2032.

The market for dermal fillers is rising rapidly, which is indicative of consumers' increasing interest in non-invasive cosmetic operations and aesthetic improvements. Injectable dermal fillers are a popular option for people looking to renew their appearance without undergoing surgery since they may smooth wrinkles, restore volume, and improve face lines. This market's expansion is being driven by a number of important factors. First of all, the need for these therapies is being fueled by the rising incidence of age-related issues, especially among aging populations, such as wrinkles and volume loss. Furthermore, there is a discernible trend toward less invasive procedures since patients favor treatments that provide efficient outcomes with shorter recovery periods. The market has grown considerably as a result of technological developments in filler compositions. Innovations like biodegradable fillers and those with improved safety profiles are drawing in eco-aware customers and giving medical professionals more treatment options. Additionally, social media's influence has produced a society in which cosmetic improvements are valued and normalized, especially among younger populations that are eager to meet idealized beauty standards. All things considered, the market for dermal fillers is expected to rise significantly over the next several years due to a confluence of demographic trends, technical advancements, and cultural changes. For example, CollPlant Biotechnologies Ltd. reported in November 2023 that the United States Patent and Trademark Office had granted a patent to its photocurable dermal filler product. The product has the ability to regenerate tissue and raise the skin.

Rising Disposable Income Boosting Market Growth

As the economy in the United States has improved and disposable income has risen more people have the means to invest in themselves. This is particularly true for millennials and Gen X who value their appearance and are willing to allocate a portion of their budget to beauty treatments. Furthermore, the perception of dermal fillers as an investment in self-care and confidence has driven the trend. Many consumers view these procedures as part of their overall appearance maintenance like skincare regimens or gym memberships. This shift in mindset has led to more acceptance of spending on cosmetic enhancements. Additionally, competition among aesthetic clinics and practitioners has driven more affordable pricing and promotions, making dermal fillers more accessible to a wider audience. As disposable income continues to rise, and the cultural acceptance of aesthetic treatments grows, the demand for dermal fillers will continue to grow and drive the market. For instance, according to the U.S. Bureau of Economic Analysis, the personal disposable income of American citizens rose from USD 18,844.03 in 2022 to USD 20,546.83 in 2023. The average disposable income of a United States citizen in the first three quarters of 2024 is USD 21,546.23, denoting a significant rise.

Technological Developments to Fuel Market Growth

Advances in filler technologies, such as the advent of hyaluronic acid-based fillers with varying degrees of cross-linking, have changed the available treatment choices. Professionals can now customize their treatments to yield better, longer-lasting benefits due to these advancements. For instance, new biodegradable and bioresorbable fillers address sustainability concerns and appeal to environmentally conscious consumers. Additionally, the application of advanced injectable techniques has improved the precision and effectiveness of dermal filler administrations, lowering recovery times and patient discomfort. The rise in minimally invasive procedures has further boosted demand as more people search for non-surgical options for aesthetic improvements. Additionally, initiatives are expanding the range of dermal filler treatments beyond traditional ones like lip augmentation and wrinkle treatment to encompass volume restoration and facial contouring as research and development continue. Technology's position as a major driver of the dermal fillers market expansion is cemented by this ongoing innovation, which not only propels market growth but also boosts customer confidence in cosmetic operations. One of the most notable advancements is the introduction of microdroplet injection techniques used with products like Juvederm Skinvive, launched in May 2024. This method allows for more precise and natural-looking enhancements by delivering smaller amounts of filler in multiple microdroplets, resulting in smoother and more subtle results that integrate seamlessly with the skin.

Biodegradable Fillers Segment Dominating Fillers Market

Biodegradable fillers are emerging as a significant driver of the global dermal fillers market, reflecting a growing consumer preference for sustainable and safe aesthetic solutions. These fillers, are made from naturally occurring substances like hyaluronic acid and poly-L-lactic acid and offer several advantages that fit in with current market trends. The biodegradable segment is particularly appealing due to its eco-friendly nature, as these fillers can be safely absorbed by the body over time, reducing the risk of long-term complications associated with non-biodegradable options. The increasing acceptance of minimally invasive procedures has further fueled the demand for biodegradable fillers. Patients appreciate their temporary results, which allow for adjustments in treatment as preferences evolve. As consumers become more environmentally conscious, the shift towards biodegradable options is expected to continue, positioning these fillers as a key growth area in the aesthetic medicine sector. This trend not only reflects changing consumer attitudes but also presents lucrative opportunities for companies involved in the development and distribution of innovative biodegradable dermal fillers. For instance, in June 2023, Galderma SA received FDA approval for its hyaluronic acid filler, Restylane Eyelight. It is used to treat undereye hollows. It improves the appearance of the under-eye area by treating the hollowness, or depression in them.

Future Market Scenario (2025 - 2032F)

The dermal filler market is set to grow because of new developments in technology, life sciences, and materials research. There is a rising need for non-invasive treatments, that will boost innovation. New technologies like AI-powered devices and super-resolution imaging, along with government funding for R&D, will help the market grow even more in the next few years. Furthermore, technological advancements like AI integration in laser devices are changing the field by improving image analysis and making research processes faster, which greatly supports market growth. Other than this, innovations are the supporting pillars of this ever-growing market. For instance, in an effort to develop powerful instruments that provide the best outcomes for practitioners and patients, Prollenium Medical Technologies Inc. announced in October 2023 that it has acquired SOFT MEDICAL AESTHETICS. This affirms their intrinsic focus on innovation to provide practitioners with powerful tools and patients with optimal results in the field of dermal fillers.

Key Players Landscape and Outlook

Key players in the dermal fillers industry are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For example, Evolus, Inc., a performance beauty company committed to offering cutting-edge products with a customer-centric approach, formally announced in May 2023 that it had finalized a deal with Symatese Inc. to act as the exclusive distributor in the United States for a line of five different dermal fillers. This filler line, EvolyseTM, is made extremely competitive on the market by the complementing effects of their quickly growing aesthetic neurotoxin, Jeuveau.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. United States Dermal Fillers Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product Type
      • 4.2.1.1. Biodegradable
      • 4.2.1.2. Non-Biodegradable
    • 4.2.2. By Application
      • 4.2.2.1. Reconstructive Surgeries
      • 4.2.2.2. Skin Treatments
      • 4.2.2.3. Others
    • 4.2.3. By Ingredients
      • 4.2.3.1. Hyaluronic Acid
      • 4.2.3.2. Calcium Hydroxylapatite
      • 4.2.3.3. Poly-L-Lactic Acid
      • 4.2.3.4. Others
    • 4.2.4. By End-user
      • 4.2.4.1. Specialty Dermatology Clinics
      • 4.2.4.2. Hospitals and Clinics
      • 4.2.4.3. Others
    • 4.2.5. By Region
      • 4.2.5.1. Northeast
      • 4.2.5.2. Midwest
      • 4.2.5.3. West
      • 4.2.5.4. South
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Product Type
    • 4.3.2. By Application
    • 4.3.3. By Ingredients
    • 4.3.4. By End-user
    • 4.3.5. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

  • 10.1. Market Drivers
  • 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

  • 12.1. Clinical Trials
  • 12.2. Regulatory Approvals

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

  • 15.1. Competition Matrix of Top 5 Market Leaders
  • 15.2. SWOT Analysis for Top 5 Players
  • 15.3. Key Players Landscape for Top 8 Market Players
    • 15.3.1. Galderma SA
      • 15.3.1.1. Company Details
      • 15.3.1.2. Key Management Personnel
      • 15.3.1.3. Products and Services
      • 15.3.1.4. Financials (As Reported)
      • 15.3.1.5. Key Market Focus and Geographical Presence
      • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 15.3.2. Bioplus Co., Ltd.
    • 15.3.3. Prollenium Medical Technologies Inc.
    • 15.3.4. BIOXIS Pharmaceuticals SAS
    • 15.3.5. Sinclair, Inc.
    • 15.3.6. Allergan Aesthetics (AbbVie Inc.)
    • 15.3.7. Medytox Inc.
    • 15.3.8. SciVision Biotech Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. United States Dermal Fillers Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. United States Dermal Fillers Market, By Volume, In Million Units, 2018-2032F
  • Figure 3. United States Dermal Fillers Market Share (%), By Product Type, 2018-2032F
  • Figure 4. United States Dermal Fillers Market Share (%), By Application, 2018-2032F
  • Figure 5. United States Dermal Fillers Market Share (%), By Ingredients, 2018-2032F
  • Figure 6. United States Dermal Fillers Market Share (%), By End-user, 2018-2032F
  • Figure 7. United States Dermal Fillers Market Share (%), By Region, 2018-2032F
  • Figure 8. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 9. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 10. By Ingredients Size Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 11. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 12. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024